Llwytho...
Recent advances of antibody drug conjugates for clinical applications
Antibody drug conjugates (ADCs) normally compose of a humanized antibody and small molecular drug via a chemical linker. After decades of preclinical and clinical studies, a series of ADCs have been widely used for treating specific tumor types in the clinic such as brentuximab vedotin (Adcetris®) f...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | Acta Pharm Sin B |
|---|---|
| Prif Awduron: | , , , , , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
Elsevier
2020
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7564033/ https://ncbi.nlm.nih.gov/pubmed/33088681 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.apsb.2020.04.012 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|